Dow reports first quarter 2026 results
Rhea-AI Summary
Dow (NYSE: DOW) reported 1Q26 results: net sales $9.8B (down 6% YoY), GAAP net loss $445M, operating EBIT $154M, and operating EPS loss $0.14. Cash from operations—continuing was $1.1B, up $1.0B YoY driven by a payment from NOVA and working capital improvements.
Volume declined 2% and local price fell 7%. Company suspended Sadara equity loss recognition and returned $252M in dividends.
Positive
- Cash provided by operating activities +$1.0B to $1.1B
- Packaging & Specialty Plastics volume gains from new Freeport polyethylene unit
- Performance Materials & Coatings Op. EBIT +$68M to $117M
- Realized cost reduction program tailwinds across segments
Negative
- Net sales down 6% YoY to $9.8B
- GAAP net loss of $445M and GAAP EPS loss of $0.74
- Local price decline of 7% and volume down 2%
- Industrial Intermediates & Infrastructure Op. EBIT loss $118M
News Market Reaction – DOW
On the day this news was published, DOW declined 0.72%, reflecting a mild negative market reaction. This price movement removed approximately $203M from the company's valuation, bringing the market cap to $27.93B at that time.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
Market Reality Check
Peers on Argus
DOW was up 1.31% pre‑results while key peers were mixed: CE -1.9%, OLN -2.85%, IFF -2.43%, MEOH +1.76%, LYB +0.29%. The pattern points to stock‑specific factors rather than a broad chemicals move.
Previous Earnings Reports
| Date | Event | Sentiment | Move | Catalyst |
|---|---|---|---|---|
| 2026-01-29 | Quarterly earnings | Negative | -2.2% | 4Q25 net sales decline and $1.5B GAAP net loss with weak EBIT. |
| 2025-10-23 | Quarterly earnings | Positive | +12.9% | 3Q25 showed GAAP net income and sequential improvement in Operating EBIT. |
| 2025-07-24 | Quarterly earnings | Negative | -17.4% | 2Q25 saw $801M GAAP loss, weak volumes and negative operating EBIT. |
| 2025-04-24 | Quarterly earnings | Negative | +2.6% | 1Q25 delivered lower sales and a GAAP net loss despite new cash support plan. |
| 2025-01-30 | Quarterly earnings | Negative | -6.1% | Q4 2024 net sales decline and GAAP net loss with lower Operating EBIT. |
Across the last five earnings reports, price usually moved in the same direction as the earnings tone, with only one instance of shares rising after weaker results.
Recent earnings releases show a series of challenging quarters with declining net sales and recurring GAAP losses, alongside a sustained focus on cost reductions and cash support. Prior quarters highlighted actions under the Transform to Outperform program, including over $6 billion in targeted improvements, asset reviews, and capital spending cuts. Cash generation has varied, from negative in 2Q25 to $1.13B in 3Q25. Today’s 1Q26 update continues that narrative of pressured pricing and volumes offset in part by cost actions and stronger operating cash flow.
Historical Comparison
Over the last five earnings releases, DOW’s average one‑day move was -2.04%, typically tracking the tone of results. The 1Q26 report extends themes of pricing pressure, cost actions, and cash generation focus.
Earnings over 2024–2025 show a shift from modest profit to recurring losses, prompting a Transform to Outperform program targeting over $6B in improvements, asset optimization, and tighter capital spending as management navigates weak pricing and volumes.
Market Pulse Summary
This announcement detailed 1Q26 results with net sales of $9.8B, a GAAP net loss of $445M, and Operating EBIT of $154M, reflecting ongoing pricing and demand pressure. At the same time, operating cash flow improved to $1.1B, supported by litigation proceeds and working capital actions. Management emphasized its Transform to Outperform cost program and Middle East conflict impacts. Investors may watch future quarters for pricing traction, margin recovery by segment, and consistency of cash generation.
Key Terms
operating ebit financial
operating ebitda financial
free cash flow financial
cash flow conversion financial
non-gaap financial
AI-generated analysis. Not financial advice.
FINANCIAL HIGHLIGHTS
- Net sales were
.8 billion, down$9 6% year-over-year, reflecting flat sales in Performance Materials & Coatings and declines in the other operating segments. - Volume decreased
2% year-over-year, driven by declines in Industrial Intermediates & Infrastructure, which was impacted by theMiddle East conflict. Gains in Packaging & Specialty Plastics from higher polyethylene volumes were more than offset by lower merchant olefins sales following the idling of a cracker inEurope , theMiddle East ,Africa andIndia (EMEAI) in mid-2025 and planned maintenance activity in theU.S. Gulf Coast. - Local price was down
7% versus the year-ago period. - The Company suspended Sadara equity loss recognition in the first quarter of 2026 in accordance with GAAP. The carrying value of all liabilities on the balance sheet reached total existing relevant obligations and commitments.
- GAAP net loss was
$445 million . Op. EBIT1 was$154 million , down$76 million year-over-year. This was primarily driven by lower prices, which were partly offset by tailwinds from the Company's cost reduction program. - GAAP loss per share was
$0.74 ; operating earnings per share (EPS)1 was a loss of$0.14 , compared to earnings of$0.02 in the year-ago period. Op. EPS excludes significant items totaling .60 per share, driven by an adjustment to the Sadara guarantee liability and taxes associated with receipt of payment from NOVA Chemicals related to the Company's ongoing litigation.$0 - Cash provided by operating activities – continuing operations was
.1 billion, up$1 .0 billion year-over-year, primarily driven by receipt of payment from NOVA Chemicals and working capital improvements.$1 - Returns to shareholders totaled
$252 million of dividends in the quarter.
CEO QUOTE
"In the first quarter, our results reflect the growing impact of Dow's self-help actions. Additionally, the margin backdrop began to positively inflect in March following global supply constraints, as impacts from the conflict in the
SUMMARY FINANCIAL RESULTS
Three Months Ended Mar 31 | |||
In millions, except per share amounts | 1Q26 | 1Q25 | vs. SQLY [B / (W)] |
Net Sales | |||
GAAP Income (Loss) Net of Tax | |||
Operating EBIT¹ | |||
Operating EBITDA¹ | |||
GAAP Earnings (Loss) Per Share | |||
Operating Earnings Per Share¹ | |||
Cash Provided by (Used for) Operating Activities – Cont. Ops | |||
1. | Op. Earnings Per Share, Op. EBIT, Op. EBIT Margin and Op. EBITDA, Free Cash Flow and Cash Flow Conversion are non-GAAP measures. See page 5 for further discussion. |
®TM Trademark of The Dow Chemical Company or an affiliated company of Dow | |
SEGMENT HIGHLIGHTS
Packaging & Specialty Plastics
Three Months Ended Mar 31 | |||
In millions | 1Q26 | 1Q25 | vs. SQLY [B / (W)] |
Net Sales | |||
Operating EBIT | |||
Packaging & Specialty Plastics segment net sales in the quarter were
Op. EBIT was
Packaging and Specialty Plastics business reported a net sales decrease versus the year-ago period, as lower polyethylene prices and lower licensing revenue were partly offset by higher volume in resilient flexible packaging applications.
Hydrocarbons & Energy business reported a net sales decrease year-over-year, driven by lower merchant olefins sales due to planned maintenance activity in the
Industrial Intermediates & Infrastructure
Three Months Ended Mar 31 | |||
In millions | 1Q26 | 1Q25 | vs. SQLY [B / (W)] |
Net Sales | |||
Operating EBIT | |||
Industrial Intermediates & Infrastructure segment net sales were
Op. EBIT increased
Polyurethanes & Construction Chemicals business reported a decrease in net sales compared to the year-ago period, primarily driven by local price, along with lower volumes from the shutdown of our higher-cost upstream propylene oxide unit in the
Industrial Solutions business reported a decrease in net sales compared to the year-ago period, as higher volumes from recent alkoxylation investments and increased demand for data center applications were more than offset by lower local prices and lower licensing revenue.
Performance Materials & Coatings
Three Months Ended Mar 31 | |||
In millions | 1Q26 | 1Q25 | vs. SQLY [B / (W)] |
Net Sales | |||
Operating EBIT | |||
Performance Materials & Coatings segment net sales in the quarter were
Op. EBIT was
Consumer Solutions business reported an increase in net sales versus the year-ago period, driven by currency tailwinds and volume gains in downstream silicones, led by gains in electronics applications globally and home and personal care applications in the
Coatings & Performance Monomers business reported a decrease in net sales compared to the year-ago period, as lower prices were partly offset by higher acrylic monomers volume, primarily in the
OUTLOOK
"We are already seeing rapid positive momentum from our announced pricing actions in every business and every region, as well as constructive impacts to our operating rates," said Fitterling. "We are leveraging Dow's purpose-built asset footprint, well-established supply chain routes and leading asset reliability to prioritize our customers and navigate the conflict in the
Conference Call
Dow will host a live webcast of its quarterly earnings conference call with investors to discuss its results, business outlook and other matters today at 8:00 a.m. ET. The webcast and slide presentation that accompany the conference call will be posted on the events and presentations page of investors.dow.com.
About Dow
Dow (NYSE: DOW) is one of the world's leading materials science companies, serving customers in high-growth markets such as packaging, infrastructure, mobility and consumer applications. Our global breadth, asset integration and scale, customer-focused innovation and leading business positions enable us to achieve profitable growth and help deliver a sustainable future. We operate manufacturing sites in 29 countries and employ approximately 34,600 people. Dow delivered sales of approximately
X: https://twitter.com/DowNewsroom
Facebook: https://www.facebook.com/dow/
LinkedIn: http://www.linkedin.com/company/dow-chemical
Instagram: http://instagram.com/dow_official
Cautionary Statement about Forward-Looking Statements
Certain statements in this press release are "forward-looking statements" within the meaning of the federal securities laws, including Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Such statements often address expected future business and financial performance, financial condition, and other matters, and often contain words or phrases such as "anticipate," "believe," "could," "estimate," "expect," "intend," "may," "opportunity," "outlook," "plan," "project," "seek," "should," "strategy," "target," "will," "will be," "will continue," "will likely result," "would" and similar expressions, and variations or negatives of these words or phrases.
Forward-looking statements are based on current assumptions and expectations of future events that are subject to risks, uncertainties and other factors that are beyond Dow's control, which may cause actual results to differ materially from those projected, anticipated or implied in the forward-looking statements and speak only as of the date the statements were made. These factors include, but are not limited to: sales of Dow's products; Dow's expenses, future revenues and profitability; any supply chain, operational or other disruptions, sanctions, export restrictions, or increased economic uncertainty related to the ongoing conflicts between
Where, in any forward-looking statement, an expectation or belief as to future results or events is expressed, such expectation or belief is based on the current plans and expectations of management and expressed in good faith and believed to have a reasonable basis, but there can be no assurance that the expectation or belief will result or be achieved or accomplished. A detailed discussion of principal risks and uncertainties which may cause actual results and events to differ materially from such forward-looking statements is included in the section titled "Risk Factors" contained in the Company's Annual Report on Form 10-K for the year ended December 31, 2025, and the Company's subsequent reports filed with the
®TM Trademark of The Dow Chemical Company or an affiliated company of Dow
Non-GAAP Financial Measures
This earnings release includes information that does not conform to GAAP and are considered non-GAAP measures. Management uses these measures internally for planning, forecasting and evaluating the performance of the Company's segments, including allocating resources. Dow's management believes that these non-GAAP measures best reflect the ongoing performance of the Company during the periods presented and provide more relevant and meaningful information to investors as they provide insight with respect to ongoing operating results of the Company and a more useful comparison of year-over-year results. These non-GAAP measures supplement the Company's GAAP disclosures and should not be viewed as alternatives to GAAP measures of performance. Furthermore, such non-GAAP measures may not be consistent with similar measures provided or used by other companies. Non-GAAP measures included in this release are defined below. Reconciliations for these non-GAAP measures to GAAP are provided in the Selected Financial Information and Non-GAAP Measures section starting on page 11. Dow does not provide forward-looking GAAP financial measures or a reconciliation of forward-looking non-GAAP financial measures to the most comparable GAAP financial measures on a forward-looking basis because the Company is unable to predict with reasonable certainty the ultimate outcome of pending litigation, unusual gains and losses, foreign currency exchange gains or losses and potential future asset impairments, as well as discrete taxable events, without unreasonable effort. These items are uncertain, depend on various factors, and could have a material impact on GAAP results for the guidance period.
Operating Earnings Per Share is defined as "Loss per common share - diluted" excluding the after-tax impact of significant items.
Operating EBIT is defined as earnings (i.e., "Loss before income taxes") before interest, excluding the impact of significant items.
Operating EBIT Margin is defined as Operating EBIT as a percentage of net sales.
Operating EBITDA is defined as earnings (i.e., "Loss before income taxes") before interest, depreciation and amortization, excluding the impact of significant items.
Free Cash Flow is defined as "Cash provided by (used for) operating activities - continuing operations," less capital expenditures. Under this definition, Free Cash Flow represents the cash generated by the Company from operations after investing in its asset base. Free Cash Flow, combined with cash balances and other sources of liquidity, represent the cash available to fund obligations and provide returns to shareholders. Free Cash Flow is an integral financial measure used in the Company's financial planning process.
Cash Flow Conversion is defined as "Cash provided by (used for) operating activities - continuing operations," divided by Operating EBITDA. Management believes Cash Flow Conversion is an important financial metric as it helps the Company determine how efficiently it is converting its earnings into cash flow.
Operating Return on Capital (ROC) is defined as net operating profit after tax, excluding the impact of significant items, divided by total average capital, also referred to as ROIC.
Dow Inc. and Subsidiaries Consolidated Statements of Income | ||
In millions, except per share amounts (Unaudited) | Three Months Ended | |
Mar 31, | Mar 31, | |
Net sales | $ 9,794 | $ 10,431 |
Cost of sales | 9,154 | 9,760 |
Research and development expenses | 181 | 200 |
Selling, general and administrative expenses | 417 | 366 |
Amortization of intangibles | 46 | 76 |
Restructuring and asset related charges - net | 27 | 208 |
Equity in losses of nonconsolidated affiliates | (303) | (20) |
Sundry income (expense) - net | 121 | 13 |
Interest income | 42 | 28 |
Interest expense and amortization of debt discount | 219 | 216 |
Loss before income taxes | (390) | (374) |
Provision (credit) for income taxes | 55 | (84) |
Net loss | (445) | (290) |
Net income attributable to noncontrolling interests | 88 | 17 |
Net loss available for Dow Inc. common stockholders | $ (533) | $ (307) |
Per common share data: | ||
Loss per common share - basic | $ (0.74) | $ (0.44) |
Loss per common share - diluted | $ (0.74) | $ (0.44) |
Weighted-average common shares outstanding - basic | 721.2 | 706.9 |
Weighted-average common shares outstanding - diluted | 721.2 | 706.9 |
Dow Inc. and Subsidiaries Consolidated Balance Sheets | ||
In millions, except share amounts (Unaudited) | Mar 31, | Dec 31, |
Assets | ||
Current Assets | ||
Cash and cash equivalents (variable interest entities restricted - 2026: | $ 4,110 | $ 3,816 |
Accounts and notes receivable: | ||
Trade (net of allowance for doubtful receivables - 2026: | 5,185 | 4,762 |
Other | 2,224 | 1,876 |
Inventories | 6,775 | 6,595 |
Other current assets | 1,175 | 1,013 |
Total current assets (variable interest entities restricted - 2026: | 19,469 | 18,062 |
Investments | ||
Investment in nonconsolidated affiliates | 1,138 | 1,264 |
Other investments (investments carried at fair value - 2026: | 3,008 | 3,017 |
Noncurrent receivables | 444 | 309 |
Total investments | 4,590 | 4,590 |
Property | ||
Property | 66,017 | 65,863 |
Less: Accumulated depreciation | 43,909 | 43,613 |
Net property (variable interest entities restricted - 2026: | 22,108 | 22,250 |
Other Assets | ||
Goodwill | 7,947 | 7,978 |
Other intangible assets (net of accumulated amortization - 2026: | 1,426 | 1,486 |
Operating lease right-of-use assets | 1,426 | 1,356 |
Deferred income tax assets | 1,525 | 1,511 |
Deferred charges and other assets | 1,289 | 1,305 |
Total other assets (variable interest entities restricted - 2026: | 13,613 | 13,636 |
Total Assets | $ 59,780 | $ 58,538 |
Liabilities and Equity | ||
Current Liabilities | ||
Notes payable | $ 88 | $ 90 |
Long-term debt due within one year | 793 | 222 |
Accounts payable: | ||
Trade | 4,769 | 4,151 |
Other | 1,392 | 1,394 |
Operating lease liabilities - current | 348 | 340 |
Income taxes payable | 344 | 337 |
Accrued and other current liabilities | 2,802 | 2,649 |
Total current liabilities (variable interest entities nonrecourse - 2026: | 10,536 | 9,183 |
Long-Term Debt (variable interest entities nonrecourse - 2026: | 17,254 | 17,849 |
Other Noncurrent Liabilities | ||
Deferred income tax liabilities | 348 | 364 |
Pension and other postretirement benefits - noncurrent | 4,542 | 4,694 |
Asbestos-related liabilities - noncurrent | 602 | 628 |
Operating lease liabilities - noncurrent | 1,146 | 1,097 |
Other noncurrent obligations | 8,589 | 7,201 |
Total other noncurrent liabilities (variable interest entities nonrecourse - 2026: | 15,227 | 13,984 |
Stockholders' Equity | ||
Common stock (authorized 5,000,000,000 shares of issued 2026: 791,896,099 shares; 2025: 790,287,565 shares) | 8 | 8 |
Additional paid-in capital | 11,062 | 11,112 |
Retained earnings | 15,992 | 16,781 |
Accumulated other comprehensive loss | (7,698) | (7,660) |
Treasury stock at cost (2026: 71,154,661 shares; 2025: 73,065,152 shares) | (4,115) | (4,233) |
Dow Inc.'s stockholders' equity | 15,249 | 16,008 |
Noncontrolling interests | 1,514 | 1,514 |
Total equity | 16,763 | 17,522 |
Total Liabilities and Equity | $ 59,780 | $ 58,538 |
Dow Inc. and Subsidiaries Consolidated Statements of Cash Flows | ||
In millions (Unaudited) | Three Months Ended | |
Mar 31, | Mar 31, | |
Operating Activities | ||
Net loss | $ (445) | $ (290) |
Adjustments to reconcile net loss to net cash provided by operating activities: | ||
Depreciation and amortization | 719 | 714 |
Credit for deferred income tax | (48) | (177) |
Earnings of nonconsolidated affiliates less than dividends received | 502 | 133 |
Net periodic pension benefit credit | (8) | (26) |
Pension contributions | (41) | (31) |
Net gain on sales of assets, businesses and investments | (4) | (2) |
Restructuring and asset related charges - net | 27 | 208 |
Other net (gain) loss | (14) | 185 |
Changes in assets and liabilities, net of effects of acquired and divested companies: | ||
Accounts and notes receivable | (531) | (301) |
Inventories | (180) | (221) |
Accounts payable | 551 | 38 |
Other assets and liabilities, net | 596 | (126) |
Cash provided by operating activities - continuing operations | 1,124 | 104 |
Cash provided by (used for) operating activities - discontinued operations | — | (13) |
Cash provided by operating activities | 1,124 | 91 |
Investing Activities | ||
Capital expenditures | (503) | (685) |
Proceeds from incentives related to capital expenditures | 40 | — |
Cash flow hedging related to capital expenditures | 3 | — |
Investment in gas field developments | (21) | (30) |
Proceeds from sales of property, businesses and consolidated companies, net of cash divested | 4 | 3 |
Investments in and loans to nonconsolidated affiliates | — | (3) |
Purchases of investments | (331) | (104) |
Proceeds from sales and maturities of investments | 319 | 416 |
Other investing activities, net | 41 | 2 |
Cash used for investing activities | (448) | (401) |
Financing Activities | ||
Changes in short-term notes payable | — | (1) |
Proceeds from issuance of short-term debt greater than three months | 4 | 11 |
Payments on short-term debt greater than three months | (4) | (6) |
Proceeds from issuance of long-term debt | 52 | 1,013 |
Payments on long-term debt | (46) | (957) |
Collections on securitization programs, net of remittances | — | 15 |
Transaction financing, debt issuance and other costs | (1) | (64) |
Employee taxes paid for share-based payment arrangements | (14) | (16) |
Distributions to noncontrolling interests | (59) | (22) |
Dividends paid to stockholders | (252) | (494) |
Cash used for financing activities | (320) | (521) |
Effect of exchange rate changes on cash, cash equivalents and restricted cash | (73) | 123 |
Summary | ||
Increase (decrease) in cash, cash equivalents and restricted cash | 283 | (708) |
Cash, cash equivalents and restricted cash at beginning of period | 3,952 | 2,263 |
Cash, cash equivalents and restricted cash at end of period | $ 4,235 | $ 1,555 |
Less: Restricted cash and cash equivalents, included in "Other current assets" | 125 | 90 |
Cash and cash equivalents at end of period | $ 4,110 | $ 1,465 |
Dow Inc. and Subsidiaries Net Sales by Segment and Geographic Region
| ||
Net Sales by Segment | Three Months Ended | |
In millions (Unaudited) | Mar 31, | Mar 31, |
Packaging & Specialty Plastics | $ 4,919 | $ 5,310 |
Industrial Intermediates & Infrastructure | 2,626 | 2,855 |
Performance Materials & Coatings | 2,080 | 2,071 |
Corporate | 169 | 195 |
Total | $ 9,794 | $ 10,431 |
$ 3,796 | $ 4,227 | |
EMEAI 1 | 3,184 | 3,274 |
1,738 | 1,858 | |
1,076 | 1,072 | |
Total | $ 9,794 | $ 10,431 |
Net Sales Variance by Segment and Geographic Region | Three Months Ended Mar 31,2026 | ||||
Local | Currency | Volume | Total | ||
Percent change from prior year | |||||
Packaging & Specialty Plastics | (9) % | 3 % | (1) % | (7) % | |
Industrial Intermediates & Infrastructure | (8) | 4 | (4) | (8) | |
Performance Materials & Coatings | (4) | 2 | 2 | — | |
Total | (7) % | 3 % | (2) % | (6) % | |
Total, excluding the Hydrocarbons & Energy business | (7) % | 3 % | — % | (4) % | |
(6) % | — % | (4) % | (10) % | ||
EMEAI 1 | (9) | 8 | (2) | (3) | |
(8) | 2 | — | (6) | ||
(9) | — | 9 | — | ||
Total | (7) % | 3 % | (2) % | (6) % | |
Europe ,Middle East ,Africa andIndia .
Dow Inc. and Subsidiaries Selected Financial Information and Non-GAAP Measures
| ||
Operating EBIT by Segment | Three Months Ended | |
In millions (Unaudited) | Mar 31, | Mar 31, |
Packaging & Specialty Plastics | $ 208 | $ 342 |
Industrial Intermediates & Infrastructure | (118) | (128) |
Performance Materials & Coatings | 117 | 49 |
Corporate | (53) | (33) |
Total | $ 154 | $ 230 |
Depreciation and Amortization by Segment | Three Months Ended | |
In millions (Unaudited) | Mar 31, | Mar 31, |
Packaging & Specialty Plastics | $ 382 | $ 360 |
Industrial Intermediates & Infrastructure | 148 | 146 |
Performance Materials & Coatings | 181 | 200 |
Corporate | 8 | 8 |
Total | $ 719 | $ 714 |
Operating EBITDA by Segment | Three Months Ended | |
In millions (Unaudited) | Mar 31, | Mar 31, |
Packaging & Specialty Plastics | $ 590 | $ 702 |
Industrial Intermediates & Infrastructure | 30 | 18 |
Performance Materials & Coatings | 298 | 249 |
Corporate | (45) | (25) |
Total | $ 873 | $ 944 |
Equity in Losses of Nonconsolidated Affiliates by Segment | Three Months Ended | |
In millions (Unaudited) | Mar 31, | Mar 31, |
Packaging & Specialty Plastics 1 | $ (63) | $ 39 |
Industrial Intermediates & Infrastructure 1 | (242) | (58) |
Performance Materials & Coatings | 1 | — |
Corporate | 1 | (1) |
Total | $ (303) | $ (20) |
Reconciliation of "Net loss" to "Operating EBIT" | Three Months Ended | |
In millions (Unaudited) | Mar 31, | Mar 31, |
Net loss | $ (445) | $ (290) |
+ Provision (credit) for income taxes | 55 | (84) |
Loss before income taxes | $ (390) | $ (374) |
- Interest income | 42 | 28 |
+ Interest expense and amortization of debt discount | 219 | 216 |
- Significant items | (367) | (416) |
Operating EBIT (non-GAAP) | $ 154 | $ 230 |
- Packaging & Specialty Plastics and Industrial Intermediates & Infrastructure include losses of
and$81 million , respectively, related to the Sadara guarantee liability adjustment, a significant item.$211 million
Dow Inc. and Subsidiaries Selected Financial Information and Non-GAAP Measures | ||||
Significant Items Impacting Results for the Three Months Ended Mar 31, 2026 | ||||
In millions, except per share amounts (Unaudited) | Pretax 1 | Net | EPS 3 | Income Statement Classification |
Reported results | $ (390) | $ (533) | $ (0.74) | |
Less: Significant items | ||||
Transform to Outperform 4 | (80) | (63) | (0.09) | SG&A ( |
2025 Restructuring implementation | (21) | (17) | (0.02) | Cost of sales ( SG&A ( |
Sadara guarantee liability adjustment 6 | (292) | (227) | (0.31) | Equity in losses of nonconsolidated |
Litigation related charges, awards and | 26 | 21 | 0.03 | Sundry income (expense) - net |
Income tax related items 8 | — | (150) | (0.21) | Provision for income taxes |
Total significant items | $ (367) | $ (436) | $ (0.60) | |
Operating results (non-GAAP) | $ (23) | $ (97) | $ (0.14) | |
Significant Items Impacting Results for the Three Months Ended Mar 31, 2025 | ||||
In millions, except per share amounts (Unaudited) | Pretax 1 | Net | EPS 3 | Income Statement Classification |
Reported results | $ (374) | $ (307) | $ (0.44) | |
Less: Significant items | ||||
Restructuring, implementation and | (51) | (39) | (0.05) | Cost of sales ( R&D ( |
2025 Restructuring Program 10 | (207) | (161) | (0.23) | Restructuring and asset related |
Loss on early extinguishment of debt | (60) | (48) | (0.07) | Sundry income (expense) - net |
Indemnification and other transaction | (98) | (76) | (0.11) | Cost of Sales |
Total significant items | $ (416) | $ (324) | $ (0.46) | |
Operating results (non-GAAP) | $ 42 | $ 17 | $ 0.02 | |
- "Loss before income taxes."
- "Net loss available for Dow Inc. common stockholders." The income tax effect on significant items was calculated based upon the enacted tax laws and statutory income tax rates applicable in the tax jurisdiction(s) of the underlying non-GAAP adjustment.
- "Losses per common share - diluted," which includes the impact of participating securities in accordance with the two-class method.
- Costs to achieve and severance and related benefit costs associated with Transform to Outperform.
- Implementation costs associated with the Company's 2025 Restructuring Program.
- Loss due to change in fair value of the estimated liability associated with the Company's guarantee of Sadara's project financing debt.
- Related to a gain associated with a legal matter with Nova Chemicals Corporation ("Nova").
- Related to tax expense associated with the legal matter with Nova.
- Restructuring charges and implementation and efficiency costs associated with the Company's 2023 Restructuring Program and impairment charges related to the write-down of certain manufacturing assets, partly offset by an asset related credit adjustment.
- Severance and related benefit costs associated with the Company's 2025 Restructuring Program.
- Includes a charge related to an arbitration settlement agreement for historical product claims from a divested business.
Dow Inc. and Subsidiaries Selected Financial Information and Non-GAAP Measures | ||
Reconciliation of Free Cash Flow | Three Months Ended | |
In millions (Unaudited) | Mar 31, | Mar 31, |
Cash provided by operating activities - continuing operations (GAAP) | $ 1,124 | $ 104 |
Capital expenditures | (503) | (685) |
Free Cash Flow (non-GAAP) | $ 621 | $ (581) |
Reconciliation of Cash Flow Conversion | Three Months Ended | |||
In millions (Unaudited) | Jun 30, | Sep 30, | Dec 31, | Mar 31, |
Cash provided by (used for) operating activities - continuing | $ (470) | $ 1,130 | $ 298 | $ 1,124 |
Net income (loss) (GAAP) | $ (801) | $ 124 | $ (445) | |
Cash flow from operations to net income (GAAP) 1 | N/A | 911.3 % | N/A | N/A |
Cash flow from operations to net income - trailing twelve months | N/A | |||
Operating EBITDA (non-GAAP) | $ 703 | $ 868 | $ 741 | $ 873 |
Cash Flow Conversion (Cash flow from operations to Operating | (66.9) % | 130.2 % | 40.2 % | 128.8 % |
Cash Flow Conversion - trailing twelve months (non-GAAP) | 65.4 % | |||
- Cash flow from operations to net income is not applicable for the second quarter and fourth quarter of 2025, and first quarter of 2026 due to a net loss for the period.
- Cash flow from operations to net income - trailing twelve months is not applicable due to a net loss for the trailing twelve months period.
For further information, please contact: | |
Investors: Andrew Riker | Media: Sarah Young |
View original content to download multimedia:https://www.prnewswire.com/news-releases/dow-reports-first-quarter-2026-results-302751593.html
SOURCE The Dow Chemical Company